Serum Integrated Screen, Part 1 (NY)

Test Code

16973

CPT Codes
Refer to Maternal Serum, Serum Integrated Screen, Part 2 (NY) (test code 16966)<br /> **This test code is for New York patient testing. For non-New York State patient testing, use Test Code 16165**

Includes

This will be reported and billed with Maternal Serum, Serum Integrated Screen, Part 2 results.

Preferred Specimen

1.5 mL serum

Minimum Volume

0.8 mL

Instructions

Collect between 9.0 weeks to 13 6/7 weeks.
Must complete patient demographic information using the Maternal Serum Screen Requisition.

Transport Container

Transport tube

Transport Temperature

Room temperature

Specimen Stability

Room temperature: 14 days
Refrigerated: 14 days
Frozen: 28 days

Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)

Moderate to gross hemolysis

Methodology
Chemiluminescence (CL) • Immunoassay (IA)

FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Setup Schedule

Set up: Mon-Sat a.m.; Report available: 4 days

Limitations

Refer to Maternal Serum, Serum Integrated Screen, Part 2 (test code 16966)

Reference Range

See Laboratory Report

Clinical Significance

When used in conjunction with part 2 testing, to assess maternal risk for carrying a fetus with down syndrome (trisomy 21), trisomy 18, or a neural tube defect. Both part 1 and part 2 are necessary to generate the risk assessment. These types of tests are standard-of-care in obstetrics.

The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.